Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Stephen How who wrote (41)	3/4/1999 7:20:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 10293

That's odd. Considering you have never mentioned buying CPU until now.

To: Stephen How who wrote (41)	3/5/1999 12:25:00 PM
From: mesaone	Read Replies (1) \| Respond to of 10293

Steve, I think you should be following your own advice.. to be through in your DD. Yes, we all expect FDA approval any day now (weeks.. soon) for Hextend, and I dont know if you were in on Abbott's conference call recently when they said that Hextend could be as much as $400 million in North American sales..hmmm.. the stock is currently selling at $16.00 and change and Abbott thinks that Hextend may generate as much as $400 million (depending on labelling), and once BTIM gets FDA approval, they will be eligible to apply for approvals in 22 countries.. Furthermore, I think that the appearance of the UPC codes going up indicate that shares are difficult to borrow. .. but please, if you feel like shorting.. could you do it on margin? mesaone inch.com